Table 3 Correlation between FoxM1 expression and clinicopathological features of glioma patients
From: Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
Clinical characteristic | NO. of patients | NO. of patients | P Valaue | |
|---|---|---|---|---|
High expression(n=26) | Low expression(n=53) | |||
Age (year) | ||||
 ≧45 | 30 | 13 | 17 | 0.102647 |
 <45 | 49 | 13 | 36 | |
Sex | ||||
 Male | 50 | 16 | 34 | 0.210681 |
 female | 29 | 10 | 19 | |
Clinical Stage | ||||
 Low grades I-II | 35 | 5 | 30 | <0.01 |
 High gradesIII - IV | 44 | 21 | 23 | |
Tumor location | ||||
Frontal | 34 | 10 | 24 | 0.357 |
Parietal | 13 | 4 | 7 | |
Occipital | 1 | 0 | 1 | |
Temporal | 18 | 6 | 12 | |
Others | 13 | 6 | 7 | |